From Yahoo Finance: 2025-05-28 13:23:00

UBS upgraded LifeStance Health Group, Inc. (NASDAQ: LFST) from Neutral to Buy, citing investor de-risking and misunderstandings. Despite a cautious outlook for Q2, LFST reported a strong Q1 with revenue up 11% to $333 million. Analyst Kevin Caliendo praised LFST’s shift to cash incentives and dismissed concerns about mental health parity rule suspension. LFST offers therapy, psychiatry, and TMS services. While LFST shows potential, some AI stocks may offer higher returns. No promotional content included.

Read more: UBS Sees Misunderstood Strength in Lifestance Health Group (LFST), Upgrades to Buy